(Q27851564)

13 November 2016

title

Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure (English)

1 reference

PubMed

PubMed publication ID

13 November 2016

1 reference

J L Dean

0 references

C Thangavel

0 references

A K McClendon

0 references

C A Reed

0 references

E S Knudsen

Estrogen Receptors as Therapeutic Targets in Breast Cancer

0 references

language of work or name

English

0 references

publication date

15 July 2010

0 references

0 references

0 references

0 references

4018-32

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.154

Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.154

The regulation of E2F by pRB-family proteins

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.154

20 April 2017

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.154

New functional activities for the p21 family of CDK inhibitors

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.154

Cyclin-dependent kinase pathways as targets for cancer treatment

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.154

CDK inhibitors: positive and negative regulators of G1-phase progression

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.154

3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.154

Requirement for CDK4 kinase function in breast cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.154

20 April 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

P21 and p27: roles in carcinogenesis and drug resistance

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Constitutive MEK/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Redundant cyclin overexpression and gene amplification in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Tailoring to RB: tumour suppressor status and therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Mammalian cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Control of pRB phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

p16 INK4 Mutations and Altered Expression in Human Tumors and Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Cyclin D1, EMS1 and 11q13 amplification in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Cyclin D-dependent kinases, INK4 inhibitors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Oestrogen receptor: a stable phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Cyclins and CDKS in development and cancer: lessons from genetically modified mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Retinoblastoma/p107/p130 pocket proteins: protein dynamics and interactions with target gene promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Treatment of growing teratoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Specific protection against breast cancers by cyclin D1 ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Rescue of Cyclin D1 Deficiency by Knockin Cyclin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

The retinoblastoma gene family in cell cycle regulation and suppression of tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154

Retinoblastoma deficiency increases chemosensitivity in lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.154